Showing results (1711-1720 of 2,088) with videos related to
Sort By:
Pageof 209
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinomaM B Atkins, J Sparano, R I Fisher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group studyK Kelly, J J Crowley, P A Bunn, et al.Biorxiv : the Preprint Server for Biology|December 18, 2023
Activation of Protein Kinase R (PKR) Plays a Pro-Viral Role in Mammarenavirus Infected CellsHaydar Witwit, Roaa Khafaji, Arul Salaniwal, et al.Molecular Medicine (Cambridge, Mass.)|March 23, 2011
Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitisQingdong Guan, Yanbing Ma, China-Li Hillman, et al.Nucleic Acids Research|October 21, 2021
Adenovirus prevents dsRNA formation by promoting efficient splicing of viral RNAAlexander M Price, Robert T Steinbock, Chao Di, et al.Cancer Chemotherapy and Pharmacology|January 27, 2022
The effects of pazopanib on doxorubicin pharmacokinetics in children and adults with non-rhabdomyosarcoma soft tissue sarcoma: a report from Children's Oncology Group and NRG Oncology study ARST1321J Gartrell, J C Panetta, S D Baker, et al.Urologic Oncology|November 23, 2005
A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group StudyMichael F Sarosdy, Catherine M Tangen, Geoffrey R Weiss, et al.Anti-Cancer Drugs|August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalatorsK A Havlin, J G Kuhn, J B Craig, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancerElizabeth A Poplin, Jacqueline K Benedetti, Norman C Estes, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1995
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitorJ W Nawrocki, S R Weiss, M H Davidson, et al.Pageof 209